StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Upgrade to SI Premium - Free Trial

Amylyx Pharmaceuticals (AMLX)

Amylyx Pharmaceuticals inc. (AMLX) PT Lowered to $3 at Baird on latest AMX0035 data April 11, 2024 6:24 AM - StreetInsider Amylyx Pharmaceuticals inc. (AMLX) PT Lowered to $3.50 at BofA Securities April 11, 2024 5:15 AM - StreetInsider Form 8-K Amylyx Pharmaceuticals, For: Apr 10 April 10, 2024 9:20 AM - SEC Filing Amylyx Pharma (AMLX) Announces Interim Data From Ongoing Phase 2 HELIOS Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome April 10, 2024 9:02 AM - StreetInsider Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Synd April 10, 2024 9:00 AM - BizWire AMLX DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important April 9 Deadline in Securities Class Action – AMLX April 8, 2024 10:05 AM - StreetInsider Amylyx Pharmaceuticals (AMLX) to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024 April 8, 2024 9:02 AM - StreetInsider Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024 April 8, 2024 9:00 AM - BizWire Amylyx Pharmaceuticals inc. (AMLX) PT Lowered to $3 at Goldman Sachs April 8, 2024 8:13 AM - StreetInsider Amylyx Pharmaceuticals inc. (AMLX) PT Lowered to $3 at Goldman Sachs April 5, 2024 6:09 AM - StreetInsider Amylyx Pharmaceuticals inc. (AMLX) PT Lowered to $4 at Deutsche Bank April 4, 2024 11:54 AM - StreetInsider Form 8-K Amylyx Pharmaceuticals, For: Apr 03 April 4, 2024 7:11 AM - SEC Filing Amylyx Pharmaceuticals (AMLX) to Remove RELYVRIO/ALBRIOZA from the Market; Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and Strategy April 4, 2024 7:02 AM - StreetInsider Amylyx Pharmaceuticals Announces Formal Intention to Remove RELYVRIO®/ALBRIOZA™ from the Market; Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and Strategy April 4, 2024 7:00 AM - BizWire SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx April 3, 2024 9:00 AM - StreetInsider AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amylyx April 1, 2024 11:30 AM - StreetInsider ROSEN, A LEADING LAW FIRM, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important April 9 Deadline in Securities Class Action – AMLX March 31, 2024 12:54 PM - StreetInsider Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NYCB, Amylyx, Xponential, and InMode and Encourages Investors to Contact the Firm March 29, 2024 9:00 PM - StreetInsider SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx March 28, 2024 9:50 AM - StreetInsider DEADLINE ALERT: Bernstein Liebhard LLP Reminds Amylyx Pharmaceuticals, Inc. Investors of Upcoming Deadline March 28, 2024 7:30 AM - StreetInsider Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, NYCB, Amylyx, and InMode and Encourages Investors to Contact the Firm March 25, 2024 9:00 PM - StreetInsider ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMLX March 25, 2024 6:17 PM - StreetInsider AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amylyx March 25, 2024 12:30 PM - StreetInsider Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, NYCB, Amylyx, and InMode and Encourages Investors to Contact the Firm March 21, 2024 9:00 PM - StreetInsider AMLX Class Action Alert: Robbins LLP Reminds Investors of Pending Lead Plaintiff Deadline – April 9, 2024 – in Amylyx Pharmaceuticals, Inc. Class Action March 21, 2024 6:07 PM - StreetInsider ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx March 19, 2024 10:15 AM - StreetInsider AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amylyx March 18, 2024 12:30 PM - StreetInsider Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, NYCB, Amylyx, and InMode and Encourages Investors to Contact the Firm March 17, 2024 9:00 PM - StreetInsider Mizuho Downgrades Amylyx Pharmaceuticals inc. (AMLX) to Neutral March 17, 2024 7:47 AM - StreetInsider ROSEN, LEADING INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMLX March 15, 2024 6:27 PM - StreetInsider Form 4 Amylyx Pharmaceuticals, For: Mar 14 Filed by: Zeiher Bernhardt G March 15, 2024 4:41 PM - SEC Filing Form 3 Amylyx Pharmaceuticals, For: Mar 14 Filed by: Zeiher Bernhardt G March 15, 2024 4:35 PM - SEC Filing SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx March 14, 2024 11:30 AM - StreetInsider Form 8-K Amylyx Pharmaceuticals, For: Mar 14 March 14, 2024 9:19 AM - SEC Filing Amylyx Pharmaceuticals (AMLX) Appoints Bernhardt Zeiher to its Board March 14, 2024 9:01 AM - StreetInsider Amylyx Pharmaceuticals Appoints Bernhardt Zeiher, MD, FCCP, FACP, to its Board of Directors March 14, 2024 9:00 AM - BizWire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GrafTech, Instacart, Cassava, and Amylyx and Encourages Investors to Contact the Firm March 12, 2024 9:00 PM - StreetInsider Amylyx Pharmaceuticals inc. (AMLX) PT Lowered to $8 at H.C. Wainwright March 12, 2024 6:39 AM - StreetInsider Amylyx Pharmaceuticals inc. (AMLX) PT Lowered to $8 at Deutsche Bank March 11, 2024 8:57 AM - StreetInsider Form SC 13G Amylyx Pharmaceuticals, Filed by: Panacea Innovation Ltd March 11, 2024 8:45 AM - SEC Filing AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amylyx March 11, 2024 8:00 AM - StreetInsider Leerink Partners Downgrades Amylyx Pharmaceuticals inc. (AMLX) to Market Perform March 11, 2024 6:07 AM - StreetInsider Goldman Sachs Downgrades Amylyx Pharmaceuticals inc. (AMLX) to Neutral March 11, 2024 2:43 AM - StreetInsider Baird Downgrades Amylyx Pharmaceuticals inc. (AMLX) to Neutral March 11, 2024 2:09 AM - StreetInsider Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GrafTech, Instacart, Cassava, and Amylyx and Encourages Investors to Contact the Firm March 8, 2024 11:30 PM - StreetInsider Goldman Sachs Downgrades Amylyx Pharmaceuticals inc. (AMLX) to Neutral March 8, 2024 2:35 PM - StreetInsider Evercore ISI Downgrades Amylyx Pharmaceuticals inc. (AMLX) to In Line March 8, 2024 9:27 AM - StreetInsider Amylyx (AMLX) Falls 70% After Phase 3 PHOENIX Trial of AMX0035 in ALS Did Not Meet Prespecified Primary or Secondary Endpoints March 8, 2024 7:13 AM - StreetInsider Form 8-K Amylyx Pharmaceuticals, For: Mar 08 March 8, 2024 7:10 AM - SEC Filing Amylyx Pharmaceuticals (AMLX) Announces Topline Results From Global Phase 3 PHOENIX Trial of AMX0035 in ALS March 8, 2024 7:00 AM - StreetInsider Amylyx Pharmaceuticals Announces Topline Results From Global Phase 3 PHOENIX Trial of AMX0035 in ALS March 8, 2024 7:00 AM - BizWire Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $32 at Mizuho March 8, 2024 6:34 AM - StreetInsider ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMLX March 7, 2024 5:40 PM - StreetInsider Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Klee Justin B. March 7, 2024 4:06 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: FRATES JAMES M March 7, 2024 4:05 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Cohen Joshua B March 7, 2024 4:05 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Mazzariello Gina March 7, 2024 4:05 PM - SEC Filing SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx March 7, 2024 9:45 AM - StreetInsider DEADLINE ALERT: Bernstein Liebhard LLP Reminds Amylyx Pharmaceuticals, Inc. Investors of Upcoming Deadline March 7, 2024 7:30 AM - StreetInsider Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, Amylyx, Sunnova, and DICK’S Sporting Goods and Encourages Investors to Contact the Firm March 4, 2024 9:00 PM - StreetInsider AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amylyx March 4, 2024 7:30 AM - StreetInsider ROSEN, NATIONAL TRIAL COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMLX March 3, 2024 3:07 PM - StreetInsider INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx March 1, 2024 9:30 AM - StreetInsider Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Boeing, Brooge, Cassava, and Amylyx and Encourages Investors to Contact the Firm February 29, 2024 9:00 PM - StreetInsider Form 4 Amylyx Pharmaceuticals, For: Feb 26 Filed by: FRATES JAMES M February 28, 2024 6:44 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Feb 26 Filed by: Cohen Joshua B February 28, 2024 6:23 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Feb 26 Filed by: Klee Justin B. February 28, 2024 6:20 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Feb 26 Filed by: Mazzariello Gina February 28, 2024 6:14 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Feb 23 Filed by: Mazzariello Gina February 27, 2024 5:59 PM - SEC Filing AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amylyx February 26, 2024 4:00 PM - StreetInsider Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Boeing, Brooge, Cassava, and Amylyx and Encourages Investors to Contact the Firm February 25, 2024 9:00 PM - StreetInsider Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) February 23, 2024 4:05 PM - BizWire AMYLYX SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Amylyx To Contact Him Directly To Discuss Th February 23, 2024 10:30 AM - StreetInsider Form S-8 Amylyx Pharmaceuticals, February 22, 2024 4:30 PM - SEC Filing Form 10-K Amylyx Pharmaceuticals, For: Dec 31 February 22, 2024 8:23 AM - SEC Filing Form 8-K Amylyx Pharmaceuticals, For: Feb 22 February 22, 2024 7:09 AM - SEC Filing Amylyx Pharmaceuticals, Inc. (AMLX) Misses Q4 EPS by 16c February 22, 2024 7:02 AM - StreetInsider Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results February 22, 2024 7:00 AM - BizWire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, and Amylyx and Encourages Investors to Contact the Firm February 21, 2024 9:00 PM - StreetInsider AMLX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Amylyx Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Case February 20, 2024 2:39 PM - StreetInsider AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amylyx February 20, 2024 8:00 AM - StreetInsider Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, and Amylyx and Encourages Investors to Contact the Firm February 17, 2024 9:00 PM - StreetInsider ROSEN, LEADING INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMLX February 16, 2024 4:29 PM - StreetInsider Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024 February 15, 2024 4:05 PM - BizWire AMYLYX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Amylyx To Contact Him Direct February 15, 2024 9:15 AM - StreetInsider Amylyx Pharmaceuticals to Present Updates on its AMX0114 and RELYVRIO® Programs in ALS at the 2024 Muscular Dystrophy Association (MDA) Clinical and Scientific Conference February 15, 2024 9:00 AM - BizWire Form SC 13G/A Amylyx Pharmaceuticals, Filed by: PERCEPTIVE ADVISORS LLC February 14, 2024 4:37 PM - SEC Filing AMLX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Amylyx Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit February 14, 2024 11:56 AM - StreetInsider Form SC 13G/A Amylyx Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP February 14, 2024 10:24 AM - SEC Filing Form SC 13G/A Amylyx Pharmaceuticals, Filed by: Point72 Asset Management, L.P. February 14, 2024 7:15 AM - SEC Filing Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, and Amylyx and Encourages Investors to Contact the Firm February 13, 2024 9:00 PM - StreetInsider Form SC 13G/A Amylyx Pharmaceuticals, Filed by: VANGUARD GROUP INC February 13, 2024 5:00 PM - SEC Filing AMYLYX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) February 12, 2024 5:00 PM - StreetInsider AMLX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Amylyx Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit February 10, 2024 1:04 PM - StreetInsider AMYLYX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Amylyx Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm February 9, 2024 9:00 PM - StreetInsider Amylyx Pharmaceuticals (AMLX) June call spreaders active as share price up 4.4% February 9, 2024 3:10 PM - StreetInsider Amylyx Pharmaceuticals Announces Completion of Enrollment in HELIOS, a Phase 2 Study of AMX0035 for the Treatment of Wolfram Syndrome February 8, 2024 9:01 AM - BizWire Form SC 13G Amylyx Pharmaceuticals, Filed by: BlackRock Inc. January 29, 2024 5:27 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Jan 25 Filed by: MILNE GEORGE M JR January 29, 2024 4:39 PM - SEC Filing Form 4 Amylyx Pharmaceuticals, For: Jan 16 Filed by: MILNE GEORGE M JR January 18, 2024 4:51 PM - SEC Filing Full Article List